07:00 Fri 02 Nov 2018
Allergy Therapeutics - Grant of Awards under Long Term Incentive Plan
("
Grant of Awards under Long Term Incentive Plan
Executive Director |
Number of Conditional shares awarded |
Total conditional shares held under LTIPs |
|
900,000 |
3,490,000 |
Nick Wykeman |
450,000 |
1,322,500 |
The Awards have been granted in accordance with the LTIP rules and vesting is conditional on the satisfaction of performance conditions in respect of earnings growth and share price growth.
In addition,
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||||||
a)
|
|
Nicolas Wykeman
|
||||||||
2
|
Reason for the notification
|
|||||||||
a)
|
Position/status
|
Nicolas Wykeman - Chief Financial Officer and PDMR |
||||||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||||
a)
|
|
|
||||||||
b)
|
LEI
|
213800PQ7AHK7KGVOE23 |
||||||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||||
a)
|
Description of the financial instrument, type of instrument
|
Conditional award of shares under the Company's Long Term Incentive Plan
|
||||||||
b) |
Identification code |
GB00B02LCQ05 |
||||||||
c)
|
Nature of the transaction
|
Grant of Conditional Awards |
||||||||
d)
|
Price(s) and volume(s)
|
|
||||||||
e)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (Single transaction)
|
||||||||
f)
|
Date of the transaction
|
|
||||||||
g)
|
Place of the transaction
|
Outside a trading venue |
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR").
For further information, please contact:
+44 (0) 1903 845 820
Nick Wykeman, Finance Director
+44 (0) 20 7886 2500
+44 20 3709 5700
allergytherapeutics@consilium-comms.com
Notes for editors:
About
Formed in 1999 out of
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE